Modulation of visceral fat by estrogens after menopause
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2013
At a glance
- Drugs Conjugated estrogens (Primary) ; Medroxyprogesterone (Primary) ; Raloxifene (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- Acronyms AFTER
- 15 Nov 2006 Status change
- 30 Oct 2006 New trial record.
- 01 Feb 2006 Primary endpoint 'Mass-of-body-fat' has not been met.